Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (362)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Editorial (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (942)
  2. Center for Hematologic Malignancies (942)
  3. Department of Medicine (942)
  4. Hematologic Malignancies, Division of (942)
  5. Survivorship Research (474)
  6. CTCR Scholars (411)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (204)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (30)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (264)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot trial of homebound hematopoietic cell transplantation
    Journal Article

    Landau, H. J.; Orlando, E.; Rodriguez, E. S.; Applebaum, A.; Mitchell, H. R.; Peled, J. U.; Khan, N.; Funnell, T.; Chung, D.; Scordo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Management of prolonged cytopenia following CAR T-cell therapy
    Correspondence

    Corona, M.; Shouval, R.; Alarcón, A.; Flynn, J.; Devlin, S.; Batlevi, C.; Mantha, S.; Palomba, M. L.; Scordo, M.; Shah, G.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
    Journal Article

    Burgos da Silva, M.; Ponce, D. M.; Dai, A.; Devlin, S. M.; Gomes, A. L. C.; Moore, G.; Slingerland, J.; Shouval, R.; Armijo, G. K.; DeWolf, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
    Journal Article

    Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Sauter, C. S.; Giralt, S. A.; Perales, M. A.; Scordo, M.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Überlegenheit von axicabtagen ciloceucel als zweitlinientherapie bei großzelligem B-zell-lymphom mit ungünstigen, mit tumoraggressivität assoziierten prognostischen faktoren im vergleich zum therapiestandard (ZUMA-7)
    Meeting Abstract

    Dreger, P.; Locke, F.; Miklos, D.; Jacobson, C.; Perales, M. A.; Kersten, M. J.; Oluwole, O.; Ghobadi, A.; Rapoport, A.; McGuirk, J.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Clinical and patient (pt)-reported outcomes (PROs) in a phase 3, randomized, open-label study evaluating axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in elderly pts with relapsed/refractory (R/R) large B-cell lymphoma (LBCL; ZUMA-7)
    Meeting Abstract

    Westin, J.; Locke, F. L.; Dickinson, M.; Ghobadi, A.; Elsawy, M.; van Meerten, T.; Miklos, D. B.; Ulrickson, M.; Perales, M. A.; Farooq, U.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Real-world outcomes of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) by race and ethnicity
    Meeting Abstract

    Locke, F. L.; Siddiqi, T.; Jacobson, C. A.; Ghobadi, A.; Ahmed, S.; Miklos, D. B.; Perales, M. A.; Munoz, J.; Logan, B.; Hu, Z. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicities (Q-TWiST) analysis of ZUMA-7, a randomized controlled trial of axicabtagene ciloleucel versus standard of care for second-line large B-cell lymphoma
    Meeting Abstract

    Kersten, M. J.; Qiao, Y.; Shah, R.; Solem, C.; Snider, J.; To, C. A.; Cheng, P.; Spooner, C.; Perales, M. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Impact of a shared-care model between community and academic centers for facilitating access to allogeneic and autologous stem cell transplantation
    Meeting Abstract

    Fein, J. A.; McAuliffe, A.; Fischer, K.; Brady, O.; Devlin, S. M.; Willumsen, S.; Ozcan, G.; Montanaro, P.; Pristyazhnyuk, Y.; Digiuseppe, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Disparities in speed to BMT consult and allograft in 279 adults with AML
    Meeting Abstract

    Fingrut, W. B.; Gyurkocza, B.; Davis, E.; Flynn, J.; Scaradavou, A.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save